Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7389 p232
25 February 2006

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

· Oxygen supplies (5)
· Community pharmacy
· Vitamin D
· Care homes
· Boots/UniChem merger
· Locum pharmacy
· Assisted dying
· Methadone
· Statins
· CPD
· Criminal convictions
· Overseas pharmacists
· National boards


Letters to the Editor

Methadone

A consistent formula is needed

From Mr R. Dunkley, MRPharmS

I dispense methadone in great quantities and to save space in my Controlled Drugs cupboard I have started buying litres of diluent, syrup and sugar substitute and gram pots of methadone powder. All one has to do is add the powder to the diluent and what results is a litre of 1mg per ml methadone mixture, which is what is required for drug addiction services.

I have never had so many complaints about the quality of the (home made) product — “it does not hold me”, “it tastes funny” and “I was rattling at 4.30am this morning”.

Even if I make the mixture up in front of customers and show them how it is made (but use a bottle I made up earlier to dispense) it does not suffice. The Drug Tariff formulary specifies that adding one to the other provides a litre of methadone mixture DTF. What are the manufacturers doing? Why can they not get a common formula? I suspect it is in the preservative, as my addict patients complain of the taste. “Ooh, it’s like Lockets” is one complaint I hear many times.

The manufacturers of the “ready made” are not off the hook — changing from one brand to another brings accusations that you are watering it down. Can there not be one formula that is consistent between manufacturers, with exactly the same ingredients? In the meantime, I and my colleagues in substance misuse management must take the flak from addicts who, having made a decision to change their lives, are being a dispensed a product that does not meet their needs.

Bob Dunkley
Dewsbury, West Yorkshire

Send your letter to The Editor

Previous Topic (Assisted dying)
Next Topic (Statins)

Back to Top


©The Pharmaceutical Journal